Erdheim-Chester disease presenting as precipitous cognitive decline

Pract Neurol. 2023 Feb;23(1):91-92. doi: 10.1136/pn-2022-003504. Epub 2022 Oct 25.

Sophie Dunkerton¹, Ross Penninkilampi², Heidi Beadnall^{3

4}, Michael Fulham^{3

4}, Andrew Colebatch³, Stacey Jankelowitz^{3

4}, Rebekah Ahmed^{3

4}, Zoe Thayer^{5

6}, Michael Halmagyi^{3

4}, Edward Abadir^{4

7}

¹ Neurology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
² Neurology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia ross.penninkilampi@health.nsw.gov.au.
³ Neurology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
⁴ The University of Sydney, Sydney, New South Wales, Australia.
⁵ Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
⁶ Macquarie University, Sydney, New South Wales, Australia.
⁷ Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

No abstract available

Keywords: CLINICAL NEUROLOGY; ERDHEIM-CHESTER DISEASE; HAEMATOLOGY; NEUROIMMUNOLOGY.

MeSH terms